These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
214 related items for PubMed ID: 25812575
1. Lentiviral vector-mediated doxycycline-inducible USP39 shRNA or cDNA expression in triple-negative breast cancer cells. Liu S, Liu X, Wang H, Zhou Q, Liang Y, Sui A, Yao R, Zhao B, Sun M. Oncol Rep; 2015 May; 33(5):2477-83. PubMed ID: 25812575 [Abstract] [Full Text] [Related]
2. Lentivirus-mediated inhibition of USP39 suppresses the growth of breast cancer cells in vitro. Wang H, Ji X, Liu X, Yao R, Chi J, Liu S, Wang Y, Cao W, Zhou Q. Oncol Rep; 2013 Dec; 30(6):2871-7. PubMed ID: 24126978 [Abstract] [Full Text] [Related]
8. Lentivirus mediated silencing of ubiquitin specific peptidase 39 inhibits cell proliferation of human hepatocellular carcinoma cells in vitro. Pan Z, Pan H, Zhang J, Yang Y, Liu H, Yang Y, Huang G, Ni J, Huang J, Zhou W. Biol Res; 2015 Mar 19; 48(1):18. PubMed ID: 25889525 [Abstract] [Full Text] [Related]
15. Down-regulating HIF-1α by lentivirus-mediated shRNA for therapy of triple negative breast cancer. Li S, Wei Q, Li Q, Zhang B, Xiao Q. Cancer Biol Ther; 2015 Sep 19; 16(6):866-75. PubMed ID: 25920936 [Abstract] [Full Text] [Related]
16. Doxycycline modulates VEGF-A expression: Failure of doxycycline-inducible lentivirus shRNA vector to knockdown VEGF-A expression in transgenic mice. Merentie M, Rissanen R, Lottonen-Raikaslehto L, Huusko J, Gurzeler E, Turunen MP, Holappa L, Mäkinen P, Ylä-Herttuala S. PLoS One; 2018 Sep 19; 13(1):e0190981. PubMed ID: 29351307 [Abstract] [Full Text] [Related]
17. Lentiviral vector-mediated survivin shRNA delivery in gastric cancer cell lines significantly inhibits cell proliferation and tumor growth. Habib R, Akhtar J, Taqi M, Yu C, Zhang C. Oncol Rep; 2015 Aug 19; 34(2):859-67. PubMed ID: 26043753 [Abstract] [Full Text] [Related]
18. A facile lentiviral vector system for expression of doxycycline-inducible shRNAs: knockdown of the pre-miRNA processing enzyme Drosha. Aagaard L, Amarzguioui M, Sun G, Santos LC, Ehsani A, Prydz H, Rossi JJ. Mol Ther; 2007 May 19; 15(5):938-45. PubMed ID: 17311008 [Abstract] [Full Text] [Related]
19. USP39, a direct target of microRNA-133a, promotes progression of pancreatic cancer via the AKT pathway. Cai J, Liu T, Huang P, Yan W, Guo C, Xiong L, Liu A. Biochem Biophys Res Commun; 2017 Apr 22; 486(1):184-190. PubMed ID: 28286270 [Abstract] [Full Text] [Related]